share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

辉瑞 | 4:持股变动声明-高管 BOURLA ALBERT
美股sec公告 ·  07/01 13:18
Moomoo AI 已提取核心信息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction on 06/28/2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Bourla after the transaction. The transaction reflects the ongoing financial activities of Pfizer's top executives and may be of interest to investors monitoring insider actions within the company.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction on 06/28/2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Bourla after the transaction. The transaction reflects the ongoing financial activities of Pfizer's top executives and may be of interest to investors monitoring insider actions within the company.
辉瑞制药公司(PFE)董事长兼首席执行官Albert Bourla于2024年06月28日执行了一笔交易。公告没有披露交易涉及的股份数量、股份性质、交易价格以及股份总价值等具体细节。报告也没有提供交易后Bourla持有股份的数量信息。这笔交易反映了辉瑞公司高层持续的财务活动,对监控公司内幕交易的投资者可能感兴趣。
辉瑞制药公司(PFE)董事长兼首席执行官Albert Bourla于2024年06月28日执行了一笔交易。公告没有披露交易涉及的股份数量、股份性质、交易价格以及股份总价值等具体细节。报告也没有提供交易后Bourla持有股份的数量信息。这笔交易反映了辉瑞公司高层持续的财务活动,对监控公司内幕交易的投资者可能感兴趣。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息